Clinical trial
Safety Study of 2DG With Stereotactic Radiosurgery
NCT00247403 · University of Iowa, Other · Withdrawn
Key facts
| NCT number | NCT00247403 |
|---|---|
| Title | Safety Study of 2DG With Stereotactic Radiosurgery |
| Official title | Phase I Clinical Trial: 2DG + Stereotactic Radiosurgery (SRS) Protocol for Treatment of Intracranial Metastases |
| Lead sponsor | University of Iowa, Other |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Intracranial Neoplasms, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | 2-deoxyglucose (2DG) |
| Enrollment | 0 |
| Start date | Oct 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Nov 1, 2005 |
| Last update posted | Apr 10, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: